coumarin has been researched along with Atrial Fibrillation in 17 studies
2H-chromen-2-one: coumarin derivative
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice." | 9.09 | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999) |
| "A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin." | 7.70 | Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000) |
| "To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice." | 5.09 | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999) |
| "The aim of the present study was to assess which clinical determinants influence coumarin and aspirin prescription in patients with atrial fibrillation in primary care." | 3.72 | Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment? ( Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ, 2003) |
| " The major drawback of coumarin therapy is the increased risk of hemorrhage." | 3.72 | Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. ( Rosendaal, FR; Torn, M; van der Meer, FJ, 2004) |
| "Anticoagulant treatment with coumarins is due to it unequivocal benefit and relatively low risk increasingly used for prevention of sudden cerebrovascular attacks, in atrial fibrillation, in the treatment of thromboembolic disease, as part of treatment after replacement of cardiac valves and other diseases." | 3.70 | [Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct]. ( Gonsorcík, J; Jonás, P; Jurgová, T; Kristian, P; Kucinský, R; Lazúr, J; Tokarcíková, A; Tomasch, J, 1998) |
| "A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin." | 3.70 | Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlieper, G | 1 |
| Schwenger, V | 1 |
| Remppis, A | 1 |
| Keller, T | 1 |
| Dechend, R | 1 |
| Massberg, S | 1 |
| Baldus, S | 1 |
| Weinreich, T | 1 |
| Hetzel, G | 1 |
| Floege, J | 2 |
| Mahfoud, F | 1 |
| Fliser, D | 1 |
| Schulman, S | 1 |
| Krüger, T | 1 |
| Hörl, WH | 1 |
| Pabinger, I | 1 |
| Tiede, A | 1 |
| Kalina, U | 1 |
| Knaub, S | 1 |
| Germann, R | 1 |
| Ostermann, H | 1 |
| Lengyel, M | 2 |
| Wijnen, PA | 1 |
| Verschakelen, JA | 1 |
| Bast, A | 1 |
| Bekers, O | 1 |
| Drent, M | 1 |
| Rutten, FH | 1 |
| Hak, E | 1 |
| Stalman, WA | 1 |
| Verheij, TJ | 1 |
| Hoes, AW | 1 |
| Geller, JC | 1 |
| Torn, M | 1 |
| van der Meer, FJ | 1 |
| Rosendaal, FR | 1 |
| Farsang, C | 1 |
| Dénes, M | 1 |
| Kiss, T | 1 |
| Gandjour, J | 1 |
| Zeindler, J | 1 |
| Georgiadis, D | 1 |
| Baumgartner, RW | 1 |
| Schipper, JP | 1 |
| Kristian, P | 1 |
| Kucinský, R | 1 |
| Gonsorcík, J | 1 |
| Jonás, P | 1 |
| Tokarcíková, A | 1 |
| Lazúr, J | 1 |
| Jurgová, T | 1 |
| Tomasch, J | 1 |
| Hellemons, BS | 1 |
| Langenberg, M | 1 |
| Lodder, J | 1 |
| Vermeer, F | 1 |
| Schouten, HJ | 1 |
| Lemmens, T | 1 |
| van Ree, JW | 1 |
| Knottnerus, JA | 1 |
| Hirsh, J | 1 |
| Dalen, J | 1 |
| Anderson, DR | 1 |
| Poller, L | 1 |
| Bussey, H | 1 |
| Ansell, J | 1 |
| Deykin, D | 1 |
| Bharat, V | 1 |
| Mohanty, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation[NCT00168077] | Phase 3 | 40 participants | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for coumarin and Atrial Fibrillation
| Article | Year |
|---|---|
[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
Topics: Anticoagulants; Atrial Fibrillation; Contraindications, Drug; Coumarins; Germany; Humans; Nephrology | 2017 |
New anticoagulants in atrial fibrillation management.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-A | 2013 |
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrilla | 2005 |
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Coumarins; Drug Interactions; Food; Heart | 2001 |
2 trials available for coumarin and Atrial Fibrillation
| Article | Year |
|---|---|
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
Topics: Aged; Anticoagulants; Antidotes; Atrial Fibrillation; Blood Coagulation Factors; Coumarins; Drug Com | 2010 |
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Ma | 1999 |
11 other studies available for coumarin and Atrial Fibrillation
| Article | Year |
|---|---|
Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit?
Topics: Animals; Anticoagulants; Atrial Fibrillation; Calcinosis; Coumarins; Humans; Mice; Quality-Adjusted | 2009 |
Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
Topics: Anticoagulants; Atrial Fibrillation; Coumarins; Humans; Kidney Failure, Chronic; Renal Dialysis; Str | 2009 |
[Guiding principles for anticoagulant therapy in cardiology].
Topics: Anticoagulants; Atrial Fibrillation; Cardiology; Cardiovascular Diseases; Coumarins; Heart Valve Pro | 2010 |
Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Coumarins; Female; Hemorrhage; | 2013 |
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Bas | 2003 |
[Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2003 |
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Coumarins; Female; Heart Valve Prosthesis | 2004 |
[Use of anticoagulant therapy in non-valvular atrial fibrillation. Analysis of a Hungarian cohort].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Coumarins | 2004 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cou | 1998 |
[Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct].
Topics: Anticoagulants; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Female; Hematoma; Hemorrh | 1998 |
Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
Topics: Amiodarone; Anticoagulants; Atrial Fibrillation; Azithromycin; Coumarins; Drug Interactions; Fatal O | 2000 |